Federated Hermes, Inc. Celldex Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $4,317 - $6,808	-121 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $3,502 - $6,774	121 New	121 $7,000
Q1 2021 May 13, 2021	SELL	$16.19 - $29.91 $1,845 - $3,409	-114 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$14.99 - $22.75 $1,019 - $1,547	68 Added 147.83%	114 $2,000
Q3 2020 Nov 12, 2020	BUY	$9.65 - $15.19 $443 - $698	46 New	46 $1,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.26B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.